Literature DB >> 21323959

Postoperative intra-arterial methylene blue injection of colorectal cancer specimens increases the number of lymph nodes recovered.

Alexander Törnroos1, Ivan Shabo, Bengt Druvefors, Gunnar Arbman, Hans Olsson.   

Abstract

AIMS: To determine the possible advantage of intra-arterial injection of methylene blue with a view to improving lymph node recovery in postoperative examination of colorectal cancer specimens. METHODS AND
RESULTS: Thirty-two colorectal cancer specimens were assigned randomly to either dissection with intra-arterial methylene blue injection or to routine dissection (without methylene blue injection). Immediately postoperatively, the specimens in the staining group were injected intra-arterially with methylene blue dye. The two procedures were compared with respect to the number of lymph nodes recovered. The number of recovered lymph nodes was significantly higher in the intra-arterial methylene blue injection group than in the group investigated with routine procedures (P<0.0001).
CONCLUSION: The intra-arterial methylene blue injection method is fairly easy to use postoperatively and increases significantly the number of lymph nodes recovered in colorectal cancer specimens.
© 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21323959     DOI: 10.1111/j.1365-2559.2011.03755.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  7 in total

1.  Ex Vivo Intra-arterial Methylene Blue Injection in Rectal Cancer Specimens Increases the Lymph-Node Harvest, Especially After Preoperative Radiation.

Authors:  Maria Münster; Uwe Hanisch; Muin Tuffaha; Rainer Kube; Henry Ptok
Journal:  World J Surg       Date:  2016-02       Impact factor: 3.352

2.  Injection of methylene blue solution into the inferior mesenteric artery of resected rectal specimens for rectal cancer as a method for increasing the lymph node harvest.

Authors:  E Klepšytė; N Evaldas Samalavičius
Journal:  Tech Coloproctol       Date:  2012-03-17       Impact factor: 3.781

3.  Lymph node hypoplasia is associated with adverse outcomes in node-negative colon cancer using advanced lymph node dissection methods.

Authors:  Patrick Mayr; Georg Aumann; Tina Schaller; Gerhard Schenkirsch; Matthias Anthuber; Bruno Märkl
Journal:  Langenbecks Arch Surg       Date:  2016-02-16       Impact factor: 3.445

4.  [Lymph node dissection after primary surgery and neoadjuvant radiochemotherapy of rectal cancer. Interim analysis of a multicenter prospective observational study (OCUM)].

Authors:  M E Kreis; C A Maurer; R Ruppert; H Ptok; J Strassburg; T Junginger; S Merkel; P Hermanek
Journal:  Chirurg       Date:  2015-12       Impact factor: 0.955

Review 5.  Stage migration vs immunology: The lymph node count story in colon cancer.

Authors:  Bruno Märkl
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

Review 6.  [Lymph node staging in gastrointestinal cancer. Combination of methylene blue-assisted lymph node dissection and ex vivo sentinel lymph node mapping].

Authors:  B Märkl; H Arnholdt
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

7.  Can Ex Vivo Magnetic Resonance Imaging of Rectal Cancer Specimens Improve the Mesorectal Lymph Node Yield for Pathological Examination?

Authors:  Rutger Stijns; Bart Philips; Carla Wauters; Johannes de Wilt; Iris Nagtegaal; Tom Scheenen
Journal:  Invest Radiol       Date:  2019-10       Impact factor: 6.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.